HCTI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HCTI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Healthcare Triangle's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.80 Mil. Healthcare Triangle's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.89 Mil. Healthcare Triangle's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-0.51 Mil. Healthcare Triangle's debt to equity for the quarter that ended in Mar. 2024 was -5.25.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Healthcare Triangle's Debt-to-Equity or its related term are showing as below:
During the past 5 years, the highest Debt-to-Equity Ratio of Healthcare Triangle was 8.02. The lowest was -5.25. And the median was 0.23.
The historical data trend for Healthcare Triangle's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare Triangle Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Debt-to-Equity | - | 0.17 | 0.21 | 0.20 | 8.02 |
Healthcare Triangle Quarterly Data | |||||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Debt-to-Equity | Get a 7-Day Free Trial | 0.32 | 0.44 | 0.57 | 8.02 | -5.25 |
For the Health Information Services subindustry, Healthcare Triangle's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Healthcare Triangle's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Healthcare Triangle's Debt-to-Equity falls into.
Debt to Equity measures the financial leverage a company has.
Healthcare Triangle's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (3.429 | + | 0.888) | / | 0.538 | |
= | 8.02 |
Healthcare Triangle's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (1.795 | + | 0.888) | / | -0.511 | |
= | -5.25 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare Triangle (NAS:HCTI) Debt-to-Equity Explanation
In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.
Be Aware
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Thank you for viewing the detailed overview of Healthcare Triangle's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Roy Sookhoo | director | 7901 STONERIDGE DR., SUITE 220, PLEASANTON CA 94588 |
Ronald W. Mcclurg | director | C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344 |
Paige Heaphy | director | 7901 STONERIDGE DR., SUITE 220, PLEASANTON CA 94588 |
Mohammad Jainal Bhuiyan | director | 10605 SW 44TH CT, DAVIE FL 33328 |
Jeffrey S Mathiesen | director | 43334 SEVEN MILE RD., SUITE 1000, NORTHVILLE MI 48167 |
Shibu Kizhakevilayil | director | 4309 HACIENDA DRIVE, SUITE 150, PLEASANTON CA 94588 |
April Bjornstad | director | 7901 STONERIDGE DRIVE, SUITE 220, PLEASANTON CA 94588 |
Thyagarajan Ramachandran | officer: Chief Financial Officer | 4309 HACIENDA DR., SUITE 150, PLEASANTON CA 94588 |
Brendan Gallagher | director | 4309 HACIENDA DR., SUITE 150, PLEASANTON CA 94588 |
James Michael Gill | officer: Vice President, Finance | 4309 HACIENDA DR., SUITE 150, PLEASANTON CA 94588 |
Mogli Sudish | officer: Chief Technology Officer | 4309 HACIENDA DRIVE, SUITE 150, PLEASANTON CA 94588 |
Vivek Prakash | director | 4309 HACIENDA DRIVE, SUITE 150, PLEASANTON CA 94588 |
Securekloud Technologies, Inc. | 10 percent owner | 401 RYLAND ST, STE 200-A, RENO NV 89502 |
Lakshmanan Kannappan | director | 4309 HACIENDA DRIVE, SUITE 150, PLEASANTON CA 94588 |
Anand Kumar | officer: Vice President, Sales | 4309 HACIENDA DR., SUITE 150, PLEASANTON CA 94588 |
From GuruFocus
By PurpleRose PurpleRose • 07-13-2022
By sperokesalga sperokesalga • 03-29-2023
By Marketwired • 09-19-2023
By Marketwired • 07-12-2023
By Value_Insider Value_Insider • 11-10-2022
By sperokesalga sperokesalga • 03-23-2023
By Marketwired • 09-12-2023
By Value_Insider Value_Insider • 10-25-2022
By sperokesalga sperokesalga • 06-13-2023
By PurpleRose PurpleRose • 07-11-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.